Allogene Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $14M | 4.8M | 2.80 |
| 2024-06-30 | $14M | 5.8M | 2.34 |
| 2024-03-31 | $19M | 4.2M | 4.47 |
| 2023-12-31 | $7.6M | 2.4M | 3.21 |
| 2023-09-30 | $7.6M | 2.4M | 3.17 |
| 2023-06-30 | $27M | 5.3M | 4.97 |
| 2023-03-31 | $31M | 6.3M | 4.94 |
| 2022-12-31 | $37M | 5.9M | 6.29 |
| 2022-03-31 | $39M | 4.3M | 9.11 |
| 2021-12-31 | $49M | 3.3M | 14.92 |
| 2021-09-30 | $112M | 4.3M | 25.70 |
| 2021-06-30 | $92M | 3.5M | 26.08 |
| 2021-03-31 | $122M | 3.5M | 35.30 |
| 2020-12-31 | $90M | 3.6M | 25.24 |
| 2020-09-30 | $135M | 3.6M | 37.71 |
| 2020-06-30 | $162M | 3.8M | 42.82 |
| 2020-03-31 | $43M | 2.2M | 19.44 |
| 2019-12-31 | $64M | 2.5M | 25.98 |
| 2019-09-30 | $69M | 2.5M | 27.25 |
| 2019-06-30 | $68M | 2.5M | 26.85 |
| 2019-03-31 | $71M | 2.5M | 28.16 |
| 2018-12-31 | $66M | 2.5M | 26.23 |